Pharmaceutical Services is a vast and varied landscape, reflecting the complexities in the discovery, development, manufacturing and monitoring of drugs and devices, all within a stringent regulatory environment. The overall growth prospects are highly favourable: drug development activity globally is on the up, led by smaller companies, which is driving demand for outsourced services. In this report we provide a breakdown of the sector into its main activity segments, and identify biologics, in ....

07 Mar 2018
Structural growth in a complex landscape
Abzena (ABZA:LON), 0 | Bioquell (BQE:LON), 0 | Consort Medical (CSRT:LON), 0 | Instem plc (INS:LON), 635 | Abzena (ABZA:LON), 0 | Ergomed PLC (ERGO:LON), 1,001 | Oxford BioMedica plc (OXB:LON), 436
-
-
-
Jens Lindqvist
-
4 pages
-

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Structural growth in a complex landscape
Abzena (ABZA:LON), 0 | Bioquell (BQE:LON), 0 | Consort Medical (CSRT:LON), 0 | Instem plc (INS:LON), 635 | Abzena (ABZA:LON), 0 | Ergomed PLC (ERGO:LON), 1,001 | Oxford BioMedica plc (OXB:LON), 436
- Published:
07 Mar 2018 -
Author:
Jens Lindqvist -
Pages:
4 -
Pharmaceutical Services is a vast and varied landscape, reflecting the complexities in the discovery, development, manufacturing and monitoring of drugs and devices, all within a stringent regulatory environment. The overall growth prospects are highly favourable: drug development activity globally is on the up, led by smaller companies, which is driving demand for outsourced services. In this report we provide a breakdown of the sector into its main activity segments, and identify biologics, in ....